Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production
- 30 April 1991
- journal article
- Published by Elsevier BV in Biologicals
- Vol. 19 (2), 113-123
- https://doi.org/10.1016/1045-1056(91)90009-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccineesVaccine, 1991
- In vitro rabies vaccine potency appraisal by ELISA: Advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibodyBiologicals, 1990
- Enhancement of interleukin-2 activity by liposomesVaccine, 1990
- Evaluation of the induction of specific cytotoxic T lymphocytes following immunization of F1 hybrid mice with rabies antigensResearch in Virology, 1989
- Rabies Virus-Specific T Cell Hybridomas: Identification of Class II MHC-Restricted T-Cell Epitopes Using Synthetic PeptidesHybridoma, 1989
- Rabies Virus-specific Human T Cell Clones Provide Help for an in vitro Antibody Response against Neutralizing Antibody-inducing Determinants of the Viral GlycoproteinJournal of General Virology, 1989
- NIH test, a problematic method for testing potency of inactivated rabies vaccineVaccine, 1988
- The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2Cellular Immunology, 1987
- Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1Nature, 1985
- Plaque formation of herpes virus hominis type 2 and rubella virus in variants isolated from the colonies of BHK21/WI-2 cells formed in soft agarArchiv für die gesamte Virusforschung, 1977